Join AVAC and TogetHER for Health on Thurs, April 25 at 8AM ET for a conversation on the importance of #HPV vaccinations among people living with HIV feat. experts from Kenya Medical Research Institute, HSPN & Jhpiego! Register here 🌟 avac.org/event/the-impo…

We were honored to have our poster displayed at the #WorldHepatitisSummit in Lisbon this week. We surveyed advocates in 29 LMICs to better understand barriers to hepatitis C Virus (HCV) care.

Read our original publication laying out the findings here: treatmentactiongroup.org/publication/wh…

Come work with TAG! We're hiring a new administrator who will handle bookkeeping duties and administer payroll, scheduling, and other office tasks. Applicants must be NYC-based. Learn more + apply here: treatmentactiongroup.org/about-us/work-…

ICYMI, TAG's second 'Breaking Barriers' webinar hosted by HIV Community Engagement Manager Antar Bush covered clinical decision-making + person-centered approaches to long-acting PrEP. Recording now available! Watch it here: treatmentactiongroup.org/webinar/naviga…

Best available treatments for drug-susceptible TB are four months long - represented by the '4' in the 1/4/6x24 Campaign, which calls for better, shorter regimens for all.
What's still needed to make that happen by the end of 2024? Read our analysis here: treatmentactiongroup.org/publication/ge…

Do you have questions on TB and Airborne IPC? The #EndTBInitiative , a #StopTB working group, is launching a new FAQ section. The ETTi team is ready to respond! Submit your question(s) with the note “Question to an Expert” here or in the comments to this post. #YesWeCanEndTB

Shout out to the amazing Tess Ryckman for contributions to important Treatment Action Group (TAG) findings: 😎👏👏👏

Switching all eligible adults to 4-month TB regimens would save 6.3 million years of treatment time by 2030, per modeling by Johns Hopkins Division of Infectious Diseases's Tess Ryckman for our 1/4/6x24 mid-campaign report. Read more on how to get shorter TB treatments by end of 2024: treatmentactiongroup.org/publication/ge…

If every eligible adult w/ drug-susceptible TB got best available 4-month regimen tomorrow, it would save 6.3 MILLION YEARS of total treatment time. That's fewer clinic visits, fewer side effects, less time away from work/school, more time living! Report: treatmentactiongroup.org/publication/ge…

#HIV -1–infected T cell clones are shared across cerebrospinal fluid and blood during ART insight.jci.org/articles/view/… (open access) JCI insight

Sunday was World Health Organization (WHO)'s #WorldHealthDay .

This year's theme is 'My health, my right' so we wanted to spotlight 4 of the Unitaid funded #LONGEVITYproject 's consortium members who have equity of healthcare access as their very foundation.

👉liverpool.ac.uk/centre-of-exce…
#WorldHealthDay 2024

👏Impressive high level leadership in Viet Nam to #EndTB ! H.E. Prime Minister Pham Minh Chinh of 🇻🇳 in special telegram has urged ministries, sectors, central & local authorities to ramp up implementation of the national #EndTB prevention & care strategy. vietnamlawmagazine.vn/pm-calls-for-e…

Funded by Unitaid and led by The Aurum Institute, the IMPAACT4TB Consortium proudly showcases how innovative finance strategies have played a key role in shaping the market for 3HP, a short-course preventive treatment for latent TB.

Find out more: the-star.co.ke/health/2024-03…

Models developed by ID's Tess Ryckman were essential to Treatment Action Group (TAG) Getting Better Faster 1/4/6x24 mid-campaign report. Read more 👇

TAG is looking for a TB Project Officer who can help advance our advocacy objectives on TB diagnostics and other key tools, community engagement in research, and more. Details here: treatmentactiongroup.org/about-us/work-…

Every year, TAG organizes a workshop before the Conference on Retroviruses and Oppotunistic Infections (CROI) to build a dialogue between researchers and HIV community members.

Watch recordings of this year's presentations + discussion here: treatmentactiongroup.org/webinar/2024-p…

📢NEWS

We are excited to announce that Unitaid have renewed funding to the #LONGEVITYproject !

This funding allows the consortium to continue research on #LongActing therapeutics to reduce the drug burden of #Tuberculosis #HepatitisC and #malaria

👉liverpool.ac.uk/centre-of-exce…

TAG’s #HIV Cure-Related Clinical Research Listing: Background on the March 2024 Update tagbasicscienceproject.typepad.com/tags_basic_sci… (a very late and long post this month)